1. Home
  2. APYX vs NKTX Comparison

APYX vs NKTX Comparison

Compare APYX & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.27

Market Cap

156.7M

Sector

Health Care

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.73

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
NKTX
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
156.7M
132.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
APYX
NKTX
Price
$3.27
$2.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.00
$13.25
AVG Volume (30 Days)
90.9K
664.6K
Earning Date
04-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
19.40
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.36
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$1.31
52 Week High
$4.50
$2.80

Technical Indicators

Market Signals
Indicator
APYX
NKTX
Relative Strength Index (RSI) 37.92 69.04
Support Level $3.30 $1.95
Resistance Level $4.40 N/A
Average True Range (ATR) 0.21 0.16
MACD -0.06 0.05
Stochastic Oscillator 19.39 92.44

Price Performance

Historical Comparison
APYX
NKTX

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: